[1]刘奇奇,高洪莲,刘蓓,等.康柏西普对豚鼠形觉剥夺性近视的干预作用及相关机制分析[J].眼科新进展,2020,40(8):722-726.[doi:10.13389/j.cnki.rao.2020.0164]
　LIU Qiqi,GAO Honglian,LIU Bei,et al.Effects of Conbercept on the form-deprivation myopia in guinea pigs and its related factors[J].Recent Advances in Ophthalmology,2020,40(8):722-726.[doi:10.13389/j.cnki.rao.2020.0164]
点击复制

康柏西普对豚鼠形觉剥夺性近视的干预作用及相关机制分析/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年8期
页码:
722-726
栏目:
实验研究
出版日期:
2020-08-05

文章信息/Info

Title:
Effects of Conbercept on the form-deprivation myopia in guinea pigs and its related factors
作者:
刘奇奇; 高洪莲; 刘蓓; 李欣蒙; 于睿; 张磊
256600　山东省滨州市，滨州医学院附属医院眼科［刘奇奇（2017级硕士研究生），刘蓓，李欣蒙（2018级硕士研究生），于睿（2018级硕士研究生），张磊］；256600　山东省滨州市，滨州医学院附属医院临床医学实验室（高洪莲）
Author(s):
LIU Qiqi1;  GAO Honglian2;  LIU Bei1;  LI Xinmeng1;  YU Rui1;  ZHANG Lei1
1.Department of Ophthalmology,the Affiliated Hospital of Binzhou Medical University,Binzhou 256600,Shandong Province,China
2.Clinical Medical Laboratory of Affiliated Hospital of Binzhou Medical University, Binzhou 256600, Shandong Province, China
关键词:
康柏西普; 形觉剥夺性近视; 基质金属蛋白酶-2; 基质金属蛋白酶抑制剂-2; 转化生长因子-β
Keywords:
Conbercept;  form-deprivation myopia;  matrix metalloproteinase-2;  tissue inhibitor of matrix metalloproteinases-2;  transforming growth factor β
分类号:
R778
DOI:
10.13389/j.cnki.rao.2020.0164
文献标志码:
A
摘要:
目的　探讨抗新生血管生长因子融合蛋白康柏西普（Conbercept）球结膜下注射对豚鼠形觉剥夺性近视的干预作用及其可能的作用机制。方法　普通级3周龄断乳花色豚鼠48只随机分为空白对照组、单纯手术组、生理盐水组、Conbercept组，每组各12只。其中空白对照组豚鼠不作处理，单纯手术组、生理盐水组、Conbercept组使用眼睑缝合法遮盖右眼，生理盐水组、Conbercept组分别在缝合时、缝合后7 d右眼球结膜下注射0.05 mL生理盐水、0.5 mg（0.05 mL）Conbercept。记录各组眼睑缝合前及缝合后7 d、14 d时的眼轴长度、屈光度，并取后极部巩膜组织采用RT-PCR、Western blot方法检测各组豚鼠巩膜中基质金属蛋白酶2（MMP-2）、基质金属蛋白酶抑制剂-2（TIMP-2）、转化生长因子（TGF）-β1、TGF-β2 mRNA和蛋白表达情况。结果　眼睑缝合后7 d、14 d，单纯手术组较空白对照组豚鼠右眼眼轴长度、屈光度均增加，MMP-2、TGF-β2 mRNA和蛋白相对表达量均增加，TGF-β1、TIMP-2相对表达量均减少，差异均具有统计学意义（均为P<0.05）；单纯手术组与生理盐水组各指标相比差异均无统计学意义（均为P>0.05)。眼睑缝合后7 d，与生理盐水组相比，Conbercept组眼轴长度、屈光度及TIMP-2、TGF-β1 mRNA和蛋白相对表达量差异均无统计学意义（均为P>0.05），MMP-2、TGF-β2 mRNA和蛋白相对表达量均减少，差异均有统计学意义（均为P<0.05）；眼睑缝合后14 d时，与生理盐水组相比，Conbercept组眼轴长度、屈光度及MMP-2、TGF-β2、TGF-β1 mRNA和蛋白相对表达量差异均有统计学意义（均为P<0.05）。结论　0.5 mg Conbercept球结膜下注射可延缓豚鼠形觉剥夺性近视形成，且可能是通过调节巩膜中的MMP-2、TGF-β1、TGF-β2表达而发挥作用。
Abstract:
Objective　To investigate the effect of subconjunctival injection of anti-angiogenic growth factor fusion protein, Conbercept, on the form-deprivation myopia in guinea pigs and its underlying mechanisms.Methods　All of 48 healthy guinea pigs (male or female) of 3 weeks old were taken. The guinea pigs were randomly divided into control group, unilateral lid fusion group, normal saline solution group and Conbercept group. Guinea pigs in the control group left untreated, and the unilateral lid fusion group, normal saline solution group and Conbercept group were treated to cover the right eye with eyelid suture. The right eye were performed with subconjunctival injection of 0.05 mL normal saline solution in the normal saline solution group, while 0.5 mg (0.05 mL) Conbercept for the Conbercept group at the time of eyelid suture and 7days after eyelid suture. Then the diopter and axial length were recorded before and 7 days and 14 days after injection, and the sclera was collected at the posterior pole for RT-PCR and Western blot to detect mRNA and protein expression levels of matrix metalloproteinases-2 (MMP-2), tissue inhibitor of matrix metalloproteinases-2 (TIMP-2), and transforming growth factor-β (TGF-β).Results　Seven days and 14 days after eyelid suture, when compared with the control group, the length of the eye axis and diopter of the right eye of guinea pigs in the unilateral lid fusion group were increased; the relative expression levels of MMP-2, TGF-β2 mRNA and protein were increased, and the relative expression levels of TGF-β1 and TIMP-2 were decreased, and the differences were statistically significant (all P<0.05). There were no statistically significant differences in all variables between the unilateral lid fusion group and normal saline solution group (all P>0.05). Seven days after eyelid suture, compared with the normal saline solution group, there were no statistically significant differences in the axial length, diopter, and relative expression of TIMP-2, TGF-β1mRNA and protein in the Conbercept group (all P>0.05), but the relative expression levels of MMP-2 and TGF-β2mRNA and protein decreased, and the differences were statistically significant (both P<0.05). At 14 days after eyelid suture, compared with normal saline solution group, the axial length, diopter and relative expression levels of MMP-2, TGF-β2, TGF-β1mRNA and protein in the Conberpt group were statistically significant (all P<0. 05). Conclusion Subconjunctival injection of 0.5 mg Conbercept can delay the formation of form-deprivation myopia in guinea pigs, which is achieved possibly by regulating the expression of MMP-2, TGF-β1 and TGF-β2 in the sclera. Conclusion　Subconjunctival injection of 0.5 mg conbercept can delay the formation of form-deprivation-myopia in guinea pigs,possibly by regulating the expression of MMP-2,TGF-β1 and TGF-β2 in the sclera.

参考文献/References:

［1］　MORGAN I G,FRENCH A N,ASHBY R S,GUO X,DING X,HE M, et al.The epidemics of myopia: Aetiology and prevention［J］.Prog Retin Eye Res,2018,62:134-149.
［2］　HOLDEN B A,FRICKE T R,WILSON D A,JONG M,NAIDOO K S,SANKARIDURG P, et al.Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050［J］.Ophthalmology,2016,123(5):1036-1042.
［3］　DOLGIN E.The myopia boom［J］.Nature,2015,519(7543):276-278.
［4］　JOACHIMSEN L,BOHRINGER D,GROSS N J,REICH M,STIFTER J,REINHARD T,et al.A pilot study on the efficacy and safety of 0.01% atropine in german school children with progressive myopia［J］.Ophthalmol Ther,2019,8(3):427-433.
［5］　SACCHI M,SERAFINO M,VILLANI E,TAGLIABUE E,LUCCARELLI S,BONSIGNORE F,et al.Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients［J］.Acta Ophthalmol,2019，97(8):e1136-e1140.
［6］　QIAN L,ZHAO H,LI X,YIN J,TANG W,CHEN P,et al.Pirenzepine inhibits myopia in guinea pig model by regulating the balance of MMP-2 and TIMP-2 expression and increased tyrosine hydroxylase levels［J］.Cell Biochem Biophys,2015,71(3):1373-1378.
［7］　VUTIPONGSATORN K,YOKOI T,OHNO-MATSUI K.Current and emerging pharmaceutical interventions for myopia［J］.Br J Ophthalmol,2019,103(11):1539-1548.
［8］　LUU C D,FOO H,CREWTHER S G,GREWTHER D P.Effects of a non-steroidal (ketorolac tromethamine) and a steroidal (dexamethasone) anti-inflammatory drug on refractive state and ocular growth［J］.Clin Exp Ophthalmol,2001,29(3):175-178.
［9］　ZHAO F,ZHOU Q,REINACH P S,YANG J,MA L,WANG X,et al.Cause and effect relationship between changes in scleral matrix metallopeptidase-2 expression and myopia development in mice［J］.Am J Pathol,2018,188(8):1754-1767.
［10］　LIU H H,KENNING M S,JOBLING A I,MCBRIEN N A,GENTLE A.Reduced scleral TIMP-2 expression is associated with myopia development: TIMP-2 supplementation stabilizes scleral biomarkers of myopia and limits myopia development［J］.Invest Ophthalmol Vis Sci,2017,58(4):1971-1981.
［11］　JIA Y,YUE Y,HU D N,CHEN J L,ZHOU J B.Human aqueous humor levels of transforming growth factor-beta2: Association with matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases［J］.Biomed Rep,2017,7(6):573-578.
［12］　CHEN B Y,WANG C Y,CHEN W Y,MA J X.Altered TGF-beta2 and bFGF expression in scleral desmocytes from an experimentally-induced myopia guinea pig model［J］.Graefes Arch Clin Exp Ophthalmol,2013,251(4):1133-1144.
［13］　刘蓓,张磊,刘玉震,高洪莲,隋文君.康柏西普对兔眼准分子激光角膜切削术术后角膜上皮下雾状混浊的影响［J］.中华实验眼科杂志,2019,37(2):94-100.
LIU B,ZHANG L,LIU Y Z,GAO H L,SUI W J.Effects of conbercept on haze formation after photorefractive keratectomy in rabbit eyes［J］.Chin J Exp Ophthalmol,2019,37(2):94-100.
［14］　CAMPBELL I C,HANNON B G,READ A T,SHERWOOD J M,SCHWANER S A,ETHIER C R.Quantification of the efficacy of collagen cross-linking agents to induce stiffening of rat sclera［J］.J R Soc Interface,2017,14(129): 20170014.
［15］　JIA Y,HU D N,ZHU D,ZHANG L,GU P,FAN X,et al.MMP-2,MMP-3,TIMP-1,TIMP-2,and TIMP-3 protein levels in human aqueous humor: relationship with axial length［J］.Invest Ophthalmol Vis Sci,2014,55(6):3922-3928.
［16］　WU H,CHEN W,ZHAO F,ZHOU Q,REINACH P S,DENG L,et al.Scleral hypoxia is a target for myopia control［J］.Proc Natl Acad Sci U S A,2018,115(30):E7091-E7100.
［17］　XI L Y,YIP S P,SHAN S W,SUMMERS-RADA J,KEE C S.Region-specific differential corneal and scleral mRNA expressions of MMP2,TIMP2,and TGFβ2 in highly myopic-astigmatic chicks［J］.Sci Rep,2017,7(1):11423.
［18］　LI T,ZHOU X,LI B,JIANG B.Effect of MT3 on retinal and choroidal TGF-beta2 and HAS2 expressions in form deprivation myopia of guinea pig［J］.J Ophthalmol,2017,2017:5028019.
［19］　MAO J,ZHANG C,LIU C,SHEN L,LAO L,SHAO Y,et al.The efficacy of intravitreal conbercept for chronic central serous chorioretinopathy［J］.J Ophthalmol,2019,2019:7409426.
［20］　DE OLIVEIRA D J,DE ANDRADE G C,NOVAIS E A,FARAH M E,RODRIGUES E B.Fusion proteins for treatment of retinal diseases: aflibercept,ziv-aflibercept, and conbercept［J］.Int J Retina Vitreous,2016,2:3.
［21］　CAI S,YANG Q,LI X,ZHANG Y.The efficacy and safety of aflibercept and conbercept in diabetic macular edema［J］.Drug Des Devel Ther,2018,12:3471-3483.
［22］　LAZZARA F,FIDILIO A,PLATANIA C,GIURDANELLA G,SALOMONE S,LEGGIO G M,et al.Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway［J］.Biochem Pharmacol,2019,168:341-351.
［23］　FOROOGHIAN F,KERTES P J,ENG K T,ALBIANI D A,KIRKER A W,MERKUR A B,et al.Alterations in intraocular cytokine levels following intravitreal ranibizumab［J］.Can J Ophthalmol,2016,51(2):87-90.
［24］　张兰兰,刘琼,于健,唐晓娟,徐静.转化生长因子-β(TGF-β)影响豚鼠巩膜成纤维细胞增殖和α-平滑肌肌动蛋白(α-SMA)表达的研究［J］.眼科新进展,2016,36(11):1011-1015.
ZHANG L L,LIU Q,YU J,TANG X J,XU J.Effects of TGF-β on cellular proliferation and α-SMA expression in guinea pig scleral fibroblasts［J］.Rec Adv Ophthalmol,2016,36(11):1011-1015.

相似文献/References:

[1]李勇子 刘桂香 王玲 隋爱玲 郭强强 万鲁芹.TIMP-2基因转染FDM豚鼠模型早期后极部巩膜中MMP-2的动态表达[J].眼科新进展,2012,32(12):000.
[2]李瑞凤 刘桂香 万鲁芹 颜晓萍 黄小凤 李勇子.TIMP-2基因转染 FDM 豚鼠后极部巩膜MMP-2蛋白早期动态表达[J].眼科新进展,2012,32(3):000.
[3]张娣,张玲,杨静,等.玻璃体内注射康柏西普联合手术及全视网膜光凝治疗新生血管性青光眼[J].眼科新进展,2015,35(12):1170.[doi:10.13389/j.cnki.rao.2015.0320]
　ZHANG Di,ZHANG Ling,YANG Jing,et al.Intravitreal injection of conbercept combined with operation and panretinal photocoagulation for neovascular glaucoma[J].Recent Advances in Ophthalmology,2015,35(8):1170.[doi:10.13389/j.cnki.rao.2015.0320]
[4]李娜,张杰,高荣玉,等.单次注射康柏西普治疗渗出型AMD患者RPE隆起面积与容积变化[J].眼科新进展,2016,36(2):172.[doi:10.13389/j.cnki.rao.2016.0047]
　LI Na,ZHANG Jie,GAO Rong-Yu,et al.Changes of retinal pigment epithelium uplift area and volume in exudative age-related macular degeneration after once injection of conbercept[J].Recent Advances in Ophthalmology,2016,36(8):172.[doi:10.13389/j.cnki.rao.2016.0047]
[5]王琛,李东豪,闻毅颐.玻璃体内注射康柏西普联合周边视网膜选择性光凝治疗视网膜静脉阻塞继发黄斑水肿的疗效及安全性[J].眼科新进展,2016,36(5):471.[doi:10.13389/j.cnki.rao.2016.0126]
　WANG Chen,LI Dong-Hao,WEN Yi-Yi.Intravitreal injection of conbercept combined with selective peripheral retinal photocoagulation for macular edema secondary to retinal vein occlusion[J].Recent Advances in Ophthalmology,2016,36(8):471.[doi:10.13389/j.cnki.rao.2016.0126]
[6]王玮,徐玲娟,蔡苏博,等.角膜基质及结膜下单次注射康柏西普治疗角膜新生血管的疗效及安全性[J].眼科新进展,2016,36(8):725.[doi:10.13389/j.cnki.rao.2016.0192]
　WANG Wei,XU Lin-Juan,CAI Su-Bo,et al.Efficacy and safety of one dose intrastromal and subconjunctival conbercept injection for corneal neovascularization[J].Recent Advances in Ophthalmology,2016,36(8):725.[doi:10.13389/j.cnki.rao.2016.0192]
[7]史志洁,张金嵩,吕晓贝.玻璃体内注射康柏西普联合手术治疗伴玻璃体积血的新生血管性青光眼[J].眼科新进展,2016,36(8):751.[doi:10.13389/j.cnki.rao.2016.0200]
　SHI Zhi-Jie,ZHANG Jin-Song,LV Xiao-Bei.Intravitreal injection of conbercept and surgical treatment for neovascular glaucoma combined with vitreous hemorrhage[J].Recent Advances in Ophthalmology,2016,36(8):751.[doi:10.13389/j.cnki.rao.2016.0200]
[8]罗顺利,许泽广,梁春正.复合式小梁切除术联合康柏西普治疗新生血管性青光眼[J].眼科新进展,2016,36(11):1076.[doi:10.13389/j.cnki.rao.2016.0287]
　LUO Shun-Li,XU Ze-Guang,LIANG Chun-Zheng.Compound trabeculectomy with conbercept for neovascular glaucoma[J].Recent Advances in Ophthalmology,2016,36(8):1076.[doi:10.13389/j.cnki.rao.2016.0287]
[9]吴若欣,徐洁慧,温积全,等.玻璃体内注射康柏西普对渗出性老年性黄斑变性患者脉络膜厚度的影响[J].眼科新进展,2016,36(12):1172.[doi:10.13389/j.cnki.rao.2016.0312]
　WU Ruo-Xin,XU Jie-Hui,WEN Ji-Quan,et al.Effects of intravitreal conbercept injections on choroidal thickness in exudative age-related macular degeneration[J].Recent Advances in Ophthalmology,2016,36(8):1172.[doi:10.13389/j.cnki.rao.2016.0312]
[10]薛鹏程,游志鹏,付书华,等.23G玻璃体切割术前、术中辅助玻璃体内注射康柏西普治疗增生型糖尿病视网膜病变（PDR）的疗效分析[J].眼科新进展,2017,37(5):458.[doi:10.13389/j.cnki.rao.2017.0116]
　XUE Peng-Cheng,YOU Zhi-Peng,FU Shu-Hua,et al.Preoperative and intraoperative adjunctive intravitreal conbercept in 23G vitrectomy for proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2017,37(8):458.[doi:10.13389/j.cnki.rao.2017.0116]
[11]邱宇,高洪莲,于睿,等.抗血管内皮生长因子玻璃体内注射对形觉剥夺性近视豚鼠视网膜中多巴胺水平的影响[J].眼科新进展,2022,42(2):113.[doi:10.13389/j.cnki.rao.2022.0023]
　QIU Yu,GAO Honglian,YU Rui,et al.Effect of intravitreal injection of anti-vascular endothelial growth factor on the dopamine level in the retina of guinea pigs with form deprivation myopia[J].Recent Advances in Ophthalmology,2022,42(8):113.[doi:10.13389/j.cnki.rao.2022.0023]

备注/Memo

备注/Memo:
山东省医药卫生科技发展计划项目（编号：2016WS0022）
更新日期/Last Update: 2020-08-05